Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.54 is 95% below its 5-year average of 30.23, near the low end of its 5-year range (1.06–81.86).
As of the fiscal period ended Tuesday, June 30, 2026. 12.53% below its 12-month average of 1.76.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.54.
CURRENT RATIO
1.54
CURRENT RATIO AVG TTM
1.76
CURRENT RATIO AVG 3Y
7.85
CURRENT RATIO AVG 5Y
30.23
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-12.53%
CURRENT VS 3Y AVG
-80.37%
CURRENT VS 5Y AVG
-94.90%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
-59.01%
vs the sector median at left
Greenwich LifeSciences, Inc.
Market Cap
$231.77M
Current Ratio
1.54
TTM Avg
1.76
3Y Avg
7.85
5Y Avg
30.23
Market Cap
$235.08M
Current Ratio
48.62
TTM Avg
31.63
3Y Avg
25.23
5Y Avg
22.81
Market Cap
$235.66M
Current Ratio
1.43
TTM Avg
1.27
3Y Avg
1.29
5Y Avg
1.36
Market Cap
$235.97M
Current Ratio
21.72
TTM Avg
10.47
3Y Avg
8.50
5Y Avg
9.09
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Greenwich LifeSciences, Inc. (GLSI) | $231.77M | 1.54 | 1.76 | 7.85 | 30.23 |
| MacroGenics, Inc. (MGNX)vs › | $231.37M | 2.96 | 4.51 | 4.52 | 4.67 |
| InflaRx N.V. (IFRX)vs › | $232.72M | 8.22 | 4.59 | 5.79 | 6.14 |
| Utah Medical Products, Inc. (UTMD)vs › | $235.08M | 48.62 | 31.63 | 25.23 | 22.81 |
| Vogenx Inc. (VOGX)vs › | $227.91M | N/A | N/A | N/A | N/A |
| Akebia Therapeutics, Inc. (AKBA)vs › | $235.66M | 1.43 | 1.27 | 1.29 | 1.36 |
| Biodesix, Inc. (BDSX)vs › | $227.60M | 2.85 | 2.31 | 2.04 | 2.06 |
| SIGA Technologies, Inc. (SIGA)vs › | $235.97M | 21.72 | 10.47 | 8.50 | 9.09 |
| BioAge Labs Inc. (BIOA)vs › | $236.82M | 17.19 | 13.55 | 8.08 | 8.08 |
| Invivyd, Inc. (IVVD)vs › | $237.57M | 5.87 | 4.43 | 7.10 | 7.89 |
Current Ratio
1.54
Quick Ratio
1.54
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.54 |
| 2026-03-31 | 2.01 |
| 2025-12-31 | 1.06 |
| 2025-09-30 | 2.35 |
| 2025-06-30 | 1.85 |
| 2025-03-31 | 1.91 |
| 2024-12-31 | 2.62 |
| 2024-09-30 | 6.91 |
| 2024-06-30 | 5.34 |
| 2024-03-31 | 14.13 |
| 2023-12-31 | 23.74 |
| 2023-09-30 | 30.76 |
| 2023-06-30 | 36.29 |
| 2023-03-31 | 50.56 |
| 2022-12-31 | 51.23 |
| 2022-09-30 | 65.74 |
| 2022-06-30 | 75.01 |
| 2022-03-31 | 81.86 |
| 2021-12-31 | 70.63 |
| 2021-09-30 | 63.51 |
| 2021-06-30 | 45.66 |
| 2021-03-31 | 45.17 |
| 2020-12-31 | 27.41 |
| 2020-09-30 | 3.87 |
| 2020-06-30 | 0.15 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 0.00 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
| 2018-12-31 | 0.12 |
